KEYTRUDA® (pembrolizumab) monotherapy patient diary

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

PDF, 1.00 MB

PDF, 1.00 MB

This downloadable resource provides patients prescribed pembrolizumab useful information on their treatment, potential side effects to look out for and allows them to make a record of any symptoms they experience.

Please ensure you click the relevant Great Britain or Northern Ireland version of the material above, depending on the location in which you practise.

To order printed versions of these diaries to your place of work, please contact msdukoncology@msd.com.

Please be aware you should not direct your patient to this website. You should download this diary on their behalf and share it with them as appropriate.

More information about KEYTRUDA® (pembrolizumab)

Visit more training and resources

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) 
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

GB-PDO-02455 | Date of Preparation: November 2022